{"id":"F2020L00520","name":"National Health (Application Fees for Pharmacist Approvals) Determination 2020","slug":"national-health-application-fees-for-pharmacist-approvals-determination-2020","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":100114,"registerId":"commonwealth-F2020L00520-current","compilationNumber":null,"startDate":"2026-04-02","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health (Application Fees for Pharmacist Approvals) Determination 2020","content":"---\nmeta-content-style-type: text/css\nmeta-content-type: application/xhtml+xml; charset=utf-8\ntitle: National Health (Application Fees for Pharmacist Approvals) Determination 2020\n---\n\n?xml version=\"1.0\" encoding=\"utf-8\" standalone=\"no\"?>\n\n![Commonwealth Coat of Arms of Australia](image.001.png)\n\nNational Health (Application Fees for Pharmacist Approvals) Determination 2020\n\nPB 31 of 2020\n\nmade under subsection 90(10) of the\n\nNational Health Act 1953\n\nCompilation No. 5\n\nCompilation date: 1 August 2025\n\nIncludes amendments: F2025L00883\n\nAbout this compilation\n\nThis compilation\n\nThis is a compilation of the National Health (Application Fees for Pharmacist Approvals) Determination 2020 that shows the text of the law as amended and in force on 1 August 2025 (the compilation date).\n\nThe notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.\n\nUncommenced amendments\n\nThe effect of uncommenced amendments is not shown in the text of the compiled law. The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au).\n\nApplication, saving and transitional provisions\n\nIf the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.\n\nEditorial changes\n\nFor more information about any editorial changes made in this compilation, see the endnotes.\n\nPresentational changes\n\nThe Legislation Act 2003 provides for First Parliamentary Counsel to make presentational changes to a compilation. Presentational changes are applied to give a more consistent look and feel to legislation published on the Register, and enable the user to more easily navigate those documents.\n\nModifications\n\nIf the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. Any modifications affecting the law are accessible on the Register.\n\nSelf‑repealing provisions\n\nIf a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.\n\n \n\n \n\n \n\nContents\n\n1 Name\n\n3 Authority\n\n4 Fees for applications\n\nEndnotes\n\nEndnote 1—About the endnotes\n\nEndnote 2—Abbreviation key\n\nEndnote 3—Legislation history\n\nEndnote 4—Amendment history\n\n \n\n1  Name\n\n (1) This instrument is the National Health (Application Fees for Pharmacist Approvals) Determination 2020.\n\n (2) This instrument may also be cited as PB 31 of 2020.\n\n3  Authority\n\n  This instrument is made under subsection 90(10) of the National Health Act 1953.\n\n4  Fees for applications\n\n  The application fee for an application under subsection 90(1) or (3) of the National Health Act 1953 is:\n\n (a) if the application must be referred to the Authority under subsection 90(3A) of the Act—$1,370; and\n\n (b) otherwise—$465.\n\nNote: The Authority mentioned in subsection 90(3A) of the National Health Act 1953 is the Australian Community Pharmacy Authority.\n\nEndnotes\n\nEndnote 1—About the endnotes\n\nThe endnotes provide information about this compilation and the compiled law.\n\nThe following endnotes are included in every compilation:\n\nEndnote 1—About the endnotes\n\nEndnote 2—Abbreviation key\n\nEndnote 3—Legislation history\n\nEndnote 4—Amendment history\n\nAbbreviation key—Endnote 2\n\nThe abbreviation key sets out abbreviations that may be used in the endnotes.\n\nLegislation history and amendment history—Endnotes 3 and 4\n\nAmending laws are annotated in the legislation history and amendment history.\n\nThe legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.\n\nThe amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.\n\nEditorial changes\n\nThe Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date.\n\nIf the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel.\n\nMisdescribed amendments\n\nA misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003.\n\nIf a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and “(md not incorp)” is added to the amendment history.\n\n \n\nEndnote 2—Abbreviation key\n\n \n\n| ad = added or inserted | orig = original |\n| --- | --- |\n| am = amended | p = page(s) |\n| amdt = amendment | para = paragraph(s)/subparagraph(s) |\n| C[x] = Compilation No. x | /sub‑subparagraph(s) |\n| ch = Chapter(s) | pres = present |\n| cl = clause(s) | prev = previous |\n| cont. = continued | (prev…) = previously |\n| def = definition(s) | pt = Part(s) |\n| Dict = Dictionary | r = regulation(s)/Court rule(s) |\n| disallowed = disallowed by Parliament | reloc = relocated |\n| div = Division(s) | renum = renumbered |\n| ed = editorial change | rep = repealed |\n| exp = expires/expired or ceases/ceased to have | rs = repealed and substituted |\n| effect | s = section(s)/subsection(s) |\n| gaz = gazette | /rule(s)/subrule(s)/order(s)/suborder(s) |\n| LA = Legislation Act 2003 | sch = Schedule(s) |\n| LIA = Legislative Instruments Act 2003 | SLI = Select Legislative Instrument |\n| (md) = misdescribed amendment can be given | SR = Statutory Rules |\n| effect | sub ch = Sub‑Chapter(s) |\n| (md not incorp) = misdescribed amendment | sub div = Subdivision(s) |\n| cannot be given effect | sub pt = Subpart(s) |\n| mod = modified/modification | underlining = whole or part not |\n| No. = Number(s) | commenced or to be commenced |\n| Ord = Ordinance |  |\n\n\n \n\n \n\nEndnote 3—Legislation history\n\n \n\n| Name | Registration | Commencement | Application, saving and transitional provisions |\n| --- | --- | --- | --- |\n| National Health (Application Fees for Pharmacist Approvals) Determination 2020 (PB 31 of 2020) | 30 Apr 2020 (F2020L00520) | 1 July 2020 (s 2(1) item 1) |  |\n| National Health (Application Fees for Pharmacist Approvals) Amendment Determination 2021 (PB 59 of 2021) | 30 June 2021 (F2021L00914) | Sch 1 (item 1): 1 July 2020 (s 2(1) item 2)  Remainder: 1 July 2021 (s 2(1) items 1, 3) | — |\n| National Health (Application Fees for Pharmacist Approvals) Amendment Determination 2022 (PB 65 of 2022) | 8 July 2022 (F2022L00962) | 1 Aug 2022 (s 2(1) item 1) | — |\n| National Health (Application Fees for Pharmacist Approvals) Amendment Determination 2024 (PB 48 of 2024) | 7 June 2024 (F2024L00658) | 1 July 2024 (s 2(1) item 1) | — |\n| National Health (Application Fees for Pharmacist Approvals) Amendment Determination 2025 (PB 73 of 2025) | 30 July 2025 (F2025L00883) | 1 Aug 2025 (s 2(1) item 1) | — |\n\n\n \n\nEndnote 4—Amendment history\n\n \n\n| Provision affected | How affected |\n| --- | --- |\n| s 2..................... | rep LA s 48D |\n| s 4..................... | am F2021L00914; F2022L00962; F2024L00658; F2025L00883 |\n\n \n","sortOrder":0}],"analysis":{"flash_summary_failed":{"failed":true,"reason":"A positive credit balance is required for all requests, including BYOK, so fallback providers remain available. Add credits at https://vercel.com/d?to=%2F%5Bteam%5D%2F%7E%2Fai%3Fmodal%3Dtop-up to continue.","source":"analysis-cron"},"kimi_summary":{"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"The legislation remains tightly focused on its original purpose of setting application fees for pharmacist approvals. Despite five amendment determinations between 2020 and 2025, these have only updated the fee amounts (indexation or policy adjustments) without expanding the scope beyond the original binary fee structure."},"complexity_factors":["Extremely short — only 4 sections, with section 2 repealed","Single operative provision (section 4) containing a simple binary fee structure","Only 2 defined fee amounts with clear conditional logic (if referred to Authority / otherwise)","Minimal cross-referencing — only references to subsections 90(1), 90(3), and 90(3A) of the parent Act","No nested exceptions, no discretionary powers, no administrative procedures described"],"plain_english_summary":"This instrument sets the application fees pharmacists must pay to be approved to supply PBS medicines under the National Health Act 1953. It creates a two‑tier fee: $1,370 for applications that require referral to the Australian Community Pharmacy Authority (ownership/location checks) and $465 for other applications. It affects pharmacy applicants and the Authority, acting as a gatekeeping, cost-reflective measure."},"flash_summary":{"complexity_score":2,"scope_assessment":{"changed":false,"description":"The instrument's substantive scope — charging application fees for pharmacist approvals under s90 of the National Health Act 1953 — remains unchanged. Amendments have altered the fee amounts (s4 amended in F2021L00914; F2022L00962; F2024L00658; F2025L00883 per Endnotes 3–4) but did not expand or narrow the categories of applications covered."},"complexity_factors":["Very short instrument: three operative clauses (name, authority, fees) which keeps structural complexity low.","Primary legal cross‑reference to National Health Act 1953 (subsection 90(1),(3),(3A)) — understanding requires checking that Act.","Simple, discrete monetary figures (two fixed fee amounts) rather than formulas or variable calculations.","Note identifies the decision body (Australian Community Pharmacy Authority) — one point of administrative discretion affects which fee applies (s4; note).","Amendment history with multiple updates to s4 (2021, 2022, 2024, 2025) raises maintenance and historical-tracking complexity for analysts comparing versions over time (Endnotes 3–4).","Low compliance complexity for applicants (payment on application), but creates a predictable financial burden that may influence applicant behaviour."],"plain_english_summary":"This instrument fixes the application fees for pharmacist approvals under the National Health Act 1953. It sets two flat fees: $1,370 where an application must be referred to the Australian Community Pharmacy Authority under s90(3A), and $465 otherwise (s4). Pharmacists seeking these approvals pay the fee on lodgement; the fee levels change the direct cost of applying and create a modest compliance cost for applicants (s4; endnotes record later amendments)."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020","history":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020/history","analysis":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020/analysis","conflicts":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020/conflicts","importantCases":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020/important-cases","documents":"/api/acts/national-health-application-fees-for-pharmacist-approvals-determination-2020/documents"}}